FDA applicant
Invitrogen Corporation
FDA records 2 decisions for Invitrogen Corporation (Grand Island) from 2002 to 2008: 1 510(k) clearance and 1 original PMA approval. Most are in product codes NYQ (Chromogenic In Situ Hybridization, Nucleic…) and NDS (Media, Culture, Ex Vivo, Tissue And Cell). Its devices cite 1 predicate, 0 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Invitrogen Corporation’s devices, and how often a recall has named them.
FDA decisions per year
1in 2008
2026 so far, outlined.
Recalls per year
1in 2018
Class I Class II/III not classified
Planning a device like Invitrogen Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report